baber/WOPTO huggingface dataset:
Patent DK-0406594-T3 (DK)
Inventor: DREWS JUERGEN
IPC: H01M4/74
Filed: 1990-06-13
Granted: 1993-11-08
Abstract: A negative electrode for lead-acid storage batteries comprises a grid plate (11) serving as the carrier for the active material and for current supply and return. The grid plate (11) is a network of plastic threads produced by a weaving process which is rendered electrically conductive by coating it, with a highly conductive thin layer of metal and additionally metallized with at least one coating of a lead-tin alloy or of lead. The grid plate (11) is subdivided into storage zones (12) produced by deep-drawing for receiving the active material and into current conducting zones (14) for current supply and return.
Patent DK-0424706-T3 (DK)
Inventor: BAUER K PROF DR CHEM
IPC: A61K9/20
Filed: 1990-10-05
Granted: 1993-05-03
Abstract: A chewable or suckable pharmaceutical form, a process for its preparation and its use as platelet aggregation inhibitor for the prophylaxis and treatment of thromboses and infarcts is described. The chewable or suckable pharmaceutical form contains 100 parts by weight of acetylsalicylic acid, 10 to 100 parts by weight of an edible acid which is used in effervescent compositions, or of an acidic salt of an acid of this type, 0 to 5000 parts by weight of polysaccharide, 10 to 100 parts by weight of edible carbonate or bicarbonate, 0 to 5000 parts by weight of protein and sugar, sugar alcohols, sweeteners, flavourings, other customary granulating and/or tabletting aids and/or chewing gum bases, in each case, where necessary, with the proviso that the pharmaceutical form must contain either polysaccharide or protein or a mixture of these two substances.
Patent DK-0444344-T3 (DK)
Inventor: SEVERANCE WAYNE STANLEY JR
IPC: B23K35/38
Filed: 1990-08-22
Granted: 1995-08-28
Abstract: A process for starting a plasma arc torch (10) is disclosed which minimizes the oxidation of the electrode (14) to thereby extend the life of the electrode (14). A flow of non-oxidizing gas is first generated between the discharge end of the torch electrode (14) and the nozzle assembly (12) of the torch (10). A pilot arc then is created between the discharge end of the electrode (14) and the nozzle assembly (12). The pilot arc is transferred and the flow of non-oxidizing gas is terminated. A flow of oxidizing gas then is generated for plasma formation.
Patent DK-0418118-T3 (DK)
Inventor: CLOUET GILBERT
IPC: C08F8/34
Filed: 1990-09-04
Granted: 1994-05-24
Abstract: These copolymers are denoted by the formulae: <IMAGE>     P1, P2 = vinyl or dienic polymer sequence (p having the value 1) or a polyoxyalkylene, polyester or polyamide one (p having the value 0); <IMAGE>   with R1 denoting, among others, alkyl; (2) <IMAGE>   where E, G and J have diverse meanings; <IMAGE>   M, joined to D, having the value <IMAGE>   h, i, Q and R having diverse meanings;   D = single bond or (cyclo)alkylene or arylene group;   n = 1 to 20.   These polymers are iniferters in the radical polymerisation of vinyl monomers. The macroiniferters (I) and the polyiniferters (II) result in triblock copolymers PA-PB-PA and diblock copolymers <IMAGE> respectively having a value from 2 to 25.
Patent DK-0456590-T3 (DK)
Inventor: LEROUX JACQUES
IPC: B23C3/05
Filed: 1991-05-03
Granted: 1994-09-05
Abstract: The present invention concerns a valve head grinding device, particularly for an internal combustion engine. 
<??>A device according to the invention comprises a rigid frame (2), a means (3) of support in rotation of the valve stem (1a), disposed in a fixed way and vertically on the frame, a stop-piece (8) for supporting in rotation the valve tail (1c), a means (9) of driving the valve in rotation by its front face (1g), disposed vertically below the means (3) of support in rotation, means (19) of compensating for the misalignment between the axis of rotation (20) of the means (9) of driving in rotation and the rigid axis of rotation (14) of the valve stem (1a), and a machining station (10), mounted on the frame (2) in an orientable manner in order to adjust the machining axis (13) with respect to the fixed and vertical referential (14) of the valve stem (1a). 
<IMAGE>
Patent DK-0528978-T3 (DK)
Inventor: TICE THOMAS R
IPC: A61K9/52
Filed: 1991-05-14
Granted: 2003-02-17
Abstract: The present invention relates to polymeric microspheres as injectable, drug-delivery systems for use to deliver bioactive agents to sites within the central nervous system, and for the stimulation of nerve fiber growth by implanting such microspheres within the central nervous system of a patient.
Patent DK-0546667-T3 (DK)
Inventor: O'BRIEN PATRICK J
IPC: G11B23/03
Filed: 1992-10-22
Granted: 1999-04-12
Abstract: A storage package (10) for a compact disc or the like has a plurality of non-plastic panels (12) including a pair of end panels (12a,12c) and, optionally, at least one panel (12b) intermediate to and connecting the pair of end panels. The plurality of panels (12) is movable between an open orientation (Fig. 2) enabling access to the contents of the package and a collapsed orientation for storage purposes, each of the panels having a pair of opposed lateral sidewalls (19), and the plurality of panels in the collapsed orientation defining at least one spine (32,34). A holder (14) formed of plastic is disposed on one (12b) of the panels for receiving and maintaining a compact disc thereon. An end cap (16) is disposed on one of the end panels or pivotally on the holder (14), the end cap being adapted to releasably engage the holder when the plurality of panels (12) is in the collapsed orientation, thereby to preclude accidental movement of the plurality of panels out of the collapsed orientation. <IMAGE>
Patent DK-0499555-T3 (DK)
Inventor: ROMAGNE FRANCOIS
IPC: G01N33/53
Filed: 1992-02-12
Granted: 2000-10-09
Abstract: Recombinant DNA containing a chimeric nucleotide sequence encoding a T cell antigen receptor chain, the said sequence consisting of:   - a sequence of mammalian origin encoding the entire variable (V), diversity (D) and junction (J) regions, - and a sequence of murine origin encoding the constant complementary region (C) which is absent from the above mammalian sequence, the two sequences being joined at a natural or artificially created restriction site,  antibodies obtained using the said DNAs,  pharmaceutical composition and diagnostic products containing them and a process for preparing them.
Patent DK-0666868-T3 (DK)
Inventor: KIM KYUNG JIN
IPC: A61K38/17
Filed: 1992-10-28
Granted: 2002-07-29
Abstract: (A) A compsn. is claimed comprising a human vascular endothelial growth factor (hVEGF) antagonist, provided however that the antagonist is not the flt or flk-1 or KOR receptor or a neutralising anti-hVEGF antibody. Also claimed are: (B) a monoclonal antibody (MAb) amino acid sequence capable of specifically binding to a HVEGF receptor (hVEGFr) or a hVEGF-hVEGFr; (C) a polypeptide comprising an amino acid sequence comprising a bVEGFr and an immunoglobulin chain; (D) a method of treatment of a tumour in a mammal comprising administering a HVEGF antagonist to reduce the size of the tumour.
Patent DK-0552810-T3 (DK)
Inventor: CLEMENTINI LUCIANO
IPC: D03D15/56
Filed: 1993-01-23
Granted: 1998-10-12
Abstract: Polyolefin yarn capable of increased resiliency and shrinkage comprising continuous strand of multiple monofilament fibers or staple fibers of propylene polymer material optionally blended with polypropylene homopolymer, said propylene polymer material selected from the group consisting of, amounts expressed as weight %:   (I) (a) random crystalline terpolymer consisting essentially of from about 96.0% to about 85.0% of propylene, from about 1.5% to about 5.0% ethylene and from about 2.5% to about 10.0% of an olefin selected from the group consisting of C4-C8 alpha-olefins; and (b) compositions of random crystalline propylene polymers comprising:     (1) from about 30 to about 65% of a copolymer of from about 80 to about 98% propylene with a C4-C8 alpha-olefin; and (2) from about 35 to about 70% of a copolymer of propylene and ethylene and optionally from about 2 to about 10% of a C4-C8 alpha-olefin; said copolymer containing from about 2 to about 10% ethylene when said C4-C8 alpha-olefin is not present and from about 0.5 to about 5% ethylene when said C4-C8 alpha-olefin is present; and     (c) compositions of random crystalline propylene polymers in combination with a predominantly ethylene copolymer consisting essentially of:   (1) about 15-35% of a terpolymer of from about 90-93% propylene and about 2-3.5% ethylene and about 5-6% C4-C8 alpha-olefin; and (2) about 30-75% of a copolymer of from about 80-90% propylene with a C4-C8 alpha-olefin; and (3) about 20-60% of a copolymer of from about 91-95% ethylene with a C4-C8 alpha-olefin; and (d) random crystalline propylene polymer comprising from about 1.5 to about 20.0 weight percent ethylene or a C4-C8 alpha-olefin;    and blends of (a), (b), (c) or (d); or   (II) (a) 90-55 parts polypropylene homopolymer having an isotactic index greater than 90 and/or crystalline copolymer of propylene with (i) ethylene and/or (ii) an  alpha -olefin of formula CH2=CHR, where R is a C2-C6 alkyl radical, comprising less than 10% of ethylene and/or  alpha -olefin; and (b) 10-45 parts of an elastomeric copolymer of propylene with comonomers of ethylene and/or an  alpha -olefin of formula CH2=CHR, where R is a C2-C6 alkyl radical containing from 50 to 70 parts by weight of comonomers, and from 10 to 40% by weight insoluble in xylene at ambient temperature. Composition (c) also can be prepared by blending, after polymerization, component (c)(3) with polymerized composition comprising components (c)(1) and (c)(2). Fabric, especially pile fabric such as carpeting is disclosed which is made from the resilient yarn and has improved appearance retention properties.   <IMAGE>
Patent DK-0599188-T3 (DK)
Inventor: DELLA VALLE FRANCESCO
IPC: A61P31/04
Filed: 1993-11-18
Granted: 1998-02-02
Abstract: Traumatic acid salts, wherein B is a pharmaceutically active cation selected from :     a) a quaternary ammonium, b) a cation of a linear or branched C1-C20 mono-, di- or tri-alkanolamine, c) a cation of a biologically active primary, secondary or tertiary amine,   d) silver or zinc cation, and relative pharmaceutical compositions administrable by topical or parenteral route for the therapeutic treatment of cutaneous pathologies in which it is important to associate an a bacteriostatic, antibiotic, antifungal or an antiviral activity, to the cicatrizant effect, typical of traumatic acid.
Patent DK-0674718-T3 (DK)
Inventor: CHASALOW FRED I
IPC: G01N33/92
Filed: 1993-09-07
Granted: 2001-12-10
Abstract: Disclosed herein are methods and a diagnostic agent for identifying HIV-infected individuals. The diagnostic agent, termed C-8.2, whose concentration is altered within about 1-3 days of HIV infection is used in assays not dependent on HIV antigens or antibodies. C-8.2 is present in the serum of all mammals and is a phospholipid or a mixture of related phospholipids.
Patent DK-0629987-T3 (DK)
Inventor: BURROWS ROGER IAN
IPC: G09B5/06
Filed: 1994-06-17
Granted: 2000-03-27
Abstract: An interactive book or device (100) having a mechanism for generating a plurality of sensory outputs in a manner that maximizes the interaction between the user and the book or device. The interactive book includes function initiators (106) for initiating a unique sensory output that corresponds to a visual indicia (114) on a page of the book (104). A function level selector (108) is coupled to the function initiators (106) that selectively changes a function level and thereby selectively changes the sensory output corresponding to each function initiator (106). Consequently, the number of sensory outputs is increased and thereby enables greater interaction between the user and the book. It also encourages the user to creatively combine the sensory outputs to obtain a cognizable aggregate output. <IMAGE>
Patent DK-0693878-T3 (DK)
Inventor: SCHMIDT WILLIAM
IPC: A01N59/12
Filed: 1994-02-24
Granted: 1997-05-05
Abstract: A protective aqueous antimicrobial film forming composition that can be applied to dairy animals to form a protective film. The film can be used to reduce the incidence of both contagious and environmental mastitis in dairy herds and can be formed from an aqueous composition that can contain a nonionic iodine complex, a polyvinyl alcohol composition, having a degree of hydrolysis greater than 92%, preferably greater than 98%, and a thickener. The aqueous mixture can be applied to udder and teats of dairy herds to form a protective coating that can prevent infection from staphlococcus, streptococcus, klebsiella and other pathogens. The film can be removed using water in a convenient short period of time permitting efficient milking operations. After milking, the composition can be reapplied to the herd and can protect the herd from mastitis until the herd is again milked. The material of the invention has the property that after application and drying both films and plugs of the protective coating is softened and removed even in cold water in a convenient time frame.
Patent DK-0649312-T3 (DK)
Inventor: ANGELUCCI FRANCESCO
IPC: A61K47/48
Filed: 1994-04-08
Granted: 2001-11-12
Abstract: PCT No. PCT/EP94/01100 Sec. 371 Date Dec. 20, 1994 Sec. 102(e) Date Dec. 20, 1994 PCT Filed Apr. 8, 1994 PCT Pub. No. WO94/26311 PCT Pub. Date Nov. 24, 1994The present invention provides polymer-bound anthracyclines of formula A which consists essentially of three units represented by formulae 1, 2 and 3:    <IMAGE>  1   <IMAGE>  2   <IMAGE>  3  wherein: Gly represents glycine; n is 0 or 1; x is from 70 to 98 mol %, y is from 1 to 29 mol %, z is from 1 to 29 mol %, R1 is a C1-C6 alkyl group substituted by one or more hydroxy groups; Y is an amino acid residue or a peptide spacer; [NH-D] is the residue of an anthracycline aminoglycoside [NH2-D]; and Z is a hydroxy group or a residue of formula -NHR1 wherein R1 is as defined above. Methods for their preparation and pharmaceutical compositions containing them are also provided.
Patent DK-0656924-T3 (DK)
Inventor: BROCK THOMAS
IPC: B05D7/14
Filed: 1994-05-25
Granted: 1997-10-27
Abstract: PCT No. PCT/EP94/01675 Sec. 371 Date Mar. 14, 1995 Sec. 102(e) Date Mar. 14, 1995 PCT Filed May 25, 1994 PCT Pub. No. WO94/28076 PCT Pub. Date Dec. 8, 1994A process is described for the multi-layer lacquer coating of a substrate by applying a base lacquer layer of an aqueous coating composition onto the optionally precoated substrate and subsequently overcoating with a clear lacquer, which contains: A) at least one copolymer containing hydroxyl groups which is obtainable by reacting a) one or more esters of aliphatic saturated monocarboxylic acids branched in  alpha -position with one or more epoxide groups in the alcohol portion with b) one or more alkyl esters of  alpha ,  beta -ethylenically unsaturated carboxylic acids, c) one or more hydroxyalkyl esters of  alpha ,  beta -ethylenically unsaturated carboxylic acids, d) optionally one or more  alpha ,  beta -ethylenically unsaturated carboxylic acids and e) optionally one or more vinyl monomers differing from a), b), c) and d), B) one or more polyisocyanates with an average of at least 1.5 NCO groups per molecule in a quantity such that the equivalent ratio of OH groups in component A) to NCO groups of component B) is 1:1.6 to 1:2.2, C) one or more solvents, optionally together with one or more customary lacquer additives.
Patent DK-0680153-T3 (DK)
Inventor: BUETOW KLAUS
IPC: H03M11/00
Filed: 1995-04-24
Granted: 2002-11-11
Abstract: The operating device has a front plate (1) incorporating one or more operating elements (4,5,6), for operating one or more components, with an applied interchangeable front foil (10). This is provided with a coding, cooperating with a code data recognition system (8), feeding the code data to an intelligent control device (9), determining the specific function of each operating element. Pref. the code data recognition system uses a number of reflection light barriers, directed onto code strips applied to the front foil, the intelligent control device using a microprocessor for initiating a number of different switch programmes dependent on the supplied code data. <IMAGE>
Patent DK-0729445-T3 (DK)
Inventor: KUMMERMEHR HANS
IPC: C04B41/50
Filed: 1994-11-11
Granted: 1999-04-12
Abstract: A mineral wool article including a mineral wool layer, at least a region of which extends from at least one surface of the mineral wool layer into the mineral wool layer to an impregnation depth t. The region of the mineral wool layer includes individual fibers and is impregnated with an impregnating substance which adheres to the fibers and encloses the fibers without sealing gaps defined between the fibers so as to permit the surface of the mineral wool layer to retain an open surface structure. The gaps between the fibers in the region include bridge formations of the impregnating substance, which bridge formations are configured to permit air to penetrate through the mineral wool layer without essentially being impeded and to trap solid particles and thereby prevent emergence of the particles from the surface of the mineral wool layer. The impregnating substance provides the article with a soft and warm touch.
Patent DK-0729329-T3 (DK)
Inventor: RINNBERG PETER
IPC: A61F13/15
Filed: 1994-11-14
Granted: 1999-09-27
Abstract: PCT No. PCT/SE94/01066 Sec. 371 Date Jun. 12, 1996 Sec. 102(e) Date Jun. 12, 1996 PCT Filed Nov. 14, 1994 PCT Pub. No. WO95/13772 PCT Pub. Date May 26, 1995A disposable diaper (10) is disclosed in which the elastic (24) which provides elasticized leg cuffs extends along substantially the entire length of each of the longitudinal edge portions (25) of the diaper between fastening means (30,32) on front and rear waist portions (20, 22 resp.) for fastening the diaper around a wearer.
Patent DK-0760649-T3 (DK)
Inventor: TAINSH DAVID ALEXANDER
IPC: A61K9/72
Filed: 1995-05-19
Granted: 2002-01-28
Abstract: PCT No. PCT/EP95/01913 Sec. 371 Date Feb. 7, 1997 Sec. 102(e) Date Feb. 7, 1997 PCT Filed May 19, 1995 PCT Pub. No. WO95/31964 PCT Pub. Date Nov. 30, 1995Suspension formulations suitable for nebulization, for administration by inhalation, comprising fluticasone propionate with a particle size less than 12 microns, one or more surfactants, one or more buffer agents and water. Also described are a method of preparing such a formulation, a container comprising the formulation, and a method of treating asthma using the formulation.
Patent DK-0772709-T3 (DK)
Inventor: BURKINSHAW STEPHEN M
IPC: D06P3/79
Filed: 1995-07-25
Granted: 2000-04-25
Abstract: A method is provide for dyeing a non-cellulosic organic material with a dye, preferably a vat dye, comprising (a) treating the material with a dye in the presence of a reducing agent and an alkali and (b) oxidising the treated material produced in step (a) characterised in that the concentration of reducing agent used in step (a) is increased above that used for conventional vat dyeing such that the resultant dyed material has a lightfastness of 5 or more by BS1006 B01 and B02 (1978) and/or has a washfastness of 5 or more by British Standard Test BS1006 CO6.C2 (1981). Preferably the step (a) is carried out in the presence of an alkali in concentration of greater than 0.1 molar, more preferably a concentration of 0.2 molar or more and most preferably greater than 1 molar. The method provides vat dyed non-cellulosic organic materials having a reflectance of infra-red light of wavelength 400 nm to 680 nm of less than 15%.
Patent DK-0796260-T3 (DK)
Inventor: FAILLI AMEDEO ARTURO
IPC: A61P37/06
Filed: 1995-12-06
Granted: 2001-09-03
Abstract: A compound of the structure   <IMAGE>   wherein X-Y is C=NOR1 or CHNHOR2; R1 and R2 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, cycloalkyl, alkyloxy, alkoxyalkyl, cycloalkylaminoalkyl, cyanoalkyl, fluoroalkyl, trifluoromethylalkyl, trifluoromethyl, ArO-, -(CH2)mAr, or -COR3; R3 is alkyl of 1-6 carbon atoms, -NH2, -NHR4, -NR4R5, or -OR4; R4 and R5 are each, independently, alkyl, Ar or if both are present can be taken together to form a 4-7 membered ring; Ar is an aryl or heteroaryl radical which may be optionally substituted; and m=0-6; or a pharmaceutically acceptable salt thereof, which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
Patent DK-0730910-T3 (DK)
Inventor: HYPPAENEN TIMO
IPC: B01J8/18
Filed: 1991-10-15
Granted: 2000-10-23
Abstract: The invention relates to a circulating fluidized bed reactor comprising a centrifugal separator and a method for separating particles from gases. The centrifugal separator (12) is a vortex chamber composed of cooling planar plates or panels (32, 34, 36) (i.e. they are distinctly non-cylindrical), having at least one gas inlet (40), at least one gas outlet (52) and at least one outlet (46) for the separated particles. The cross section of the side walls (32, 34, 36) of the vortex chamber forms a distinctly non-circular gas space (31) (e.g. a polygonal cross section), have a circularity of greater than 1, e.g. > 1.1, and preferably > 1.15. One or more vertical, parallel gas vortices may be created in the vortex chamber, the gas introduced into vertical narrow slots. The outlets (46) for separated particles are not one the same symmetrical axes as the outlets for purified gas (52). Two adjacent vortices may be provided in a common rectangular chamber. The separator (12) is preferably in conjunction with a circulating fluidized bed reactor (10).
Patent DK-0807398-T3 (DK)
Inventor: SARGEANT ADRIAN ANTHONY
IPC: A47L15/00
Filed: 1992-12-18
Granted: 2004-07-05
Abstract: A dishwasher comprising: a wash chamber adapted to accommodate dishes and within which wash liquid is circulated, a rack within said chamber which supports dishes above the floor of said chamber, a rotatable spray arm having liquid discharge nozzles located in the bottom of said wash chamber under said rack, a pump which pressurises said spray arm with wash liquid, and mounting means located centrally in the floor of said chamber which rotatably supports said spray arm, said spray arm in turn comprising a hub portion and two diametrically opposed wing portions extending outwardly therefrom towards the side walls of said chamber, and said wing portions shaped such that they droop downwardly away from the hub portion.
Patent DK-0922392-T3 (DK)
Inventor: BRAUN MARCEL
IPC: A23L33/18
Filed: 1997-12-12
Granted: 2003-06-23
Abstract: A liquid protein hydrolysate-based food is made by partial enzymatic hydrolysis of a protein-containing starting material, packaging under sterile conditions and completing the hydrolysis in the packaging container. A process for producing a food product based on a protein hydrolysate in liquid form comprises: (a) adjusting the pH of a liquid non-hydrolyzed or partially hydrolyzed protein-containing starting material to a value of 6 - 9 by addition of a base before or after sterilization, in the latter case by addition of a sterilized base; (b) adding, under aseptic conditions, a proteolytic enzyme in an amount sufficient to provide the required degree of hydrolysis of the protein in the starting material; (c) packaging the hot material under aseptic conditions and hermetically sealing the packaging containers; and (d) allowing the packaged mixture to complete the hydrolysis within the packaging container.
Patent DK-0915858-T3 (DK)
Inventor: BUFORN ALBERT
IPC: C07D233/86
Filed: 1997-07-17
Granted: 2000-11-20
Abstract: Novel 2-thio-thiazolidine-5-one compounds useful as intermediates for fungicidal 2-imidazoline-5-ones are disclosed.